Related Experiment Video
Updated: Dec 21, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Ke Xu1, Dongkyoo Park1, Andrew T Magis2
1Division of Cancer Biology, Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA.
This study has an amendment. Please refer to the original article for the most current information and findings.
Area of Science:
- Not specified in the abstract.
Background:
- The original study details are not provided.
Purpose of the Study:
- To inform readers about a published amendment.
Main Methods:
- No methods are described in the provided abstract.
Main Results:
- No results are described in the provided abstract.
Conclusions:
- Readers should consult the original article to access the amendment.
More Related Videos
07:08Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer